|Day's Range||0.0830 - 0.0880|
|52 Week Range||0.0600 - 0.5500|
|PE Ratio (TTM)||-1.29|
|Earnings Date||Aug 8, 2017 - Aug 14, 2017|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||3.00|
The following letter is being released by CEL-SCI Corporation to its shareholders:
CEL-SCI Corporation today announced that Daniel Zimmerman, Ph.D., Senior Vice President of Research, Cellular Immunology, presented additional data on its LEAPS rheumatoid arthritis vaccine candidates CEL-4000 and CEL-2000 at IMMUNOLOGY 2017, the annual meeting of the American Association of Immunologists , May 12 – 16 in Washington, D.C.
CEL-SCI Corporation today announced it has changed the date for its annual meeting from June 9, 2017 to June 12, 2017.